Literature DB >> 10514475

Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway.

M Murakami1, T Kambe, S Shimbara, S Yamamoto, H Kuwata, I Kudo.   

Abstract

An emerging body of evidence suggests that type IIA secretory phospholipase A(2) (sPLA(2)-IIA) participates in the amplification of the stimulus-induced cyclooxygenase (COX)-2-dependent delayed prostaglandin (PG)-biosynthetic response in several cell types. However, the biological importance of the ability of sPLA(2)-IIA to bind to heparan sulfate proteoglycan (HSPG) on cell surfaces has remained controversial. Here we show that glypican, a glycosylphosphatidylinositol (GPI)-anchored HSPG, acts as a physical and functional adaptor for sPLA(2)-IIA. sPLA(2)-IIA-dependent PGE(2) generation by interleukin-1-stimulated cells was markedly attenuated by treatment of the cells with heparin, heparinase or GPI-specific phospholipase C, which solubilized the cell surface-associated sPLA(2)-IIA. Overexpression of glypican-1 increased the association of sPLA(2)-IIA with the cell membrane, and glypican-1 was coimmunoprecipitated by the antibody against sPLA(2)-IIA. Glypican-1 overexpression led to marked augmentation of sPLA(2)-IIA-mediated arachidonic acid release, PGE(2) generation, and COX-2 induction in interleukin-1-stimulated cells, particularly when the sPLA(2)-IIA expression level was suboptimal. Immunofluorescent microscopic analyses of cytokine-stimulated cells revealed that sPLA(2)-IIA was present in the caveolae, a microdomain in which GPI-anchored proteins reside, and also appeared in the perinuclear area in proximity to COX-2. We therefore propose that a GPI-anchored HSPG glypican facilitates the trafficking of sPLA(2)-IIA into particular subcellular compartments, and arachidonic acid thus released from the compartments may link efficiently to the downstream COX-2-mediated PG biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514475     DOI: 10.1074/jbc.274.42.29927

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Inhibition of phospholipase A(2) activity by conjugated linoleic acids in human macrophages.

Authors:  Ewa Stachowska; Violetta Dziedziejko; Krzysztof Safranow; Izabela Gutowska; Grazyna Adler; Andrzej Ciechanowicz; Bogusław Machaliński; Dariusz Chlubek
Journal:  Eur J Nutr       Date:  2006-12-11       Impact factor: 5.614

2.  Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.

Authors:  Jun Saegusa; Nobuaki Akakura; Chun-Yi Wu; Case Hoogland; Zi Ma; Kit S Lam; Fu-Tong Liu; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

3.  Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis.

Authors:  Anthony J Monteforte; Brian Lam; Subhamoy Das; Somshuvra Mukhopadhyay; Catherine S Wright; Patricia E Martin; Andrew K Dunn; Aaron B Baker
Journal:  Biomaterials       Date:  2016-04-11       Impact factor: 12.479

4.  Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells.

Authors:  Michiko Mitsuishi; Seiko Masuda; Ichiro Kudo; Makoto Murakami
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 5.  Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists.

Authors:  Grace Y Sun; Jianfeng Xu; Michael D Jensen; Sue Yu; W Gibson Wood; Fernando A González; Agnes Simonyi; Albert Y Sun; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

6.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

Review 7.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

8.  Pharmacological study of edema and myonecrosis in mice induced by venom of the bushmaster snake (Lachesis muta muta) and its basic Asp49 phospholipase A(2) (LmTX-I).

Authors:  Daniela C S Damico; Maria Alice da Cruz Höfling; Mariana Cintra; Marta B Leonardo; Andrana K Calgarotto; Saulo L da Silva; Sérgio Marangoni
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

9.  Over-expression of caveolin-1 aggravate LPS-induced inflammatory response in AT-1 cells via up-regulation of cPLA2/p38 MAPK.

Authors:  Xue-Jun Lv; Yu-Ying Li; Yong-Juan Zhang; Mei Mao; Gui-Sheng Qian
Journal:  Inflamm Res       Date:  2010-01-23       Impact factor: 4.575

Review 10.  Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes.

Authors:  Robert S Rosenson; Michael H Gelb
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.